2
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Neoplasms
47
Breast Neoplasms
32
Colorectal Neoplasms
28
Prostatic Neoplasms
27
Lung Neoplasms
17
Hematopoietic and Lymphatic System Neoplasm
13
Hematologic Neoplasms
12
Ovarian Neoplasms
11
Uterine Cervical Neoplasms
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Multiple Myeloma
7
Lymphoma
7
Leukemia
7
Head and Neck Neoplasms
6
Endometrial Neoplasms
6
Depression
6
Rectal Neoplasms
5
Pancreatic Neoplasms
5
Leukemia, Myeloid, Acute
5
Urinary Bladder Neoplasms
4
Mouth Neoplasms
4
Motor Activity
4
Melanoma
4
Malignant Solid Neoplasm
4
Hematopoietic and Lymphoid System Neoplasm
4
Gastrointestinal Neoplasms
4
Colonic Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Anxiety Disorders
4
Advanced Cancer
4
Interventions
Ipilimumab
29
Nivolumab
23
pembrolizumab
14
incomplete Freund's adjuvant
10
Cyclophosphamide
10
Melphalan
9
Interleukin-2
9
CTLA-4 Antigen
8
tebentafusp
7
sargramostim
7
Temozolomide
7
MART-1 Antigen
7
Dacarbazine
7
Ranibizumab
6
montanide ISA 51
5
fludarabine phosphate
5
fludarabine
5
Sunitinib
5
Radiosurgery
5
Carboplatin
5
Blood Specimen Collection
5
Bevacizumab
5
aldesleukin
4
aflibercept
4
Surveys and Questionnaires
4
Magnetic Resonance Spectroscopy
4
Granulocyte-Macrophage Colony-Stimulating Factor
4
Biopsy
4
trametinib
3
sotrastaurin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Uveal Melanoma
×
Interviews as Topic
×
Clear all
NCT06073548
2023-10-10
SALOME Quali
Institut Curie
Unknown
250 enrolled